Infliximab-induced psoriasis in a patient with crohn′s disease
نویسندگان
چکیده
منابع مشابه
Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
Tumor necrosis factor-α (TNFα) inhibition is an effective treatment of moderate-to-severe psoriasis and other diseases (rheumatoid arthritis, ankylosing spondylitis, psoriasis or Crohn's disease). We report a case of a 32-years-old patient affected by Crohn's disease since the age of 25 who started infliximab infusion after four years of treatment with prednisone and azathioprine per os without...
متن کاملPsoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis.
Although the therapeutic uses of tumor necrosis factor alpha antagonists have added a highly effective treatment of ankylosing spondylitis and associated spondyloarthropathies, they are associated with many untoward effects. We describe a Saudi patient with ankylosing spondylitis who developed severe psoriatic lesions in treatment with infliximab. He had no personal, or family history of psoria...
متن کاملFlexural or Inverse Psoriasis in a Patient With Hidradenitis Suppurativa Receiving Treatment With Infliximab.
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that is found predominantly in the flexures. The regions with a high density of apocrine glands (axillas, groin, buttocks, inframammary region, and perianal region) are those most often affected and the disease has a marked impact on the quality of life of patients. Though many therapeutic options are available, the response i...
متن کاملInfliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
Treatment with antitumor necrosis factor-alpha (anti-TNF-α) offers a significant improvement in several immune-based diseases, including Crohn's disease (CD) and psoriasis. Different cutaneous side effects have been described for anti-TNF-α therapy such as psoriasis. Previous reports showed that inhibition of TNF-α can induce over expression of cutaneous IFN-α, which in turn caused a predisposi...
متن کاملEffect of infliximab top-down therapy on weight gain in pediatric Crohns disease.
This retrospective-medical-record review was conducted to evaluate effect of infliximab therapy, particularly with a top-down strategy, on the nutritional parameters of children with Crohns disease (CD). 42 patients who were diagnosed with Crohns disease at the Pediatric Gastroenterology center of a tertiary care teaching hospital and achieved remission at two months and one year after beginnin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Saudi Journal of Medicine and Medical Sciences
سال: 2015
ISSN: 1658-631X
DOI: 10.4103/1658-631x.149695